{"nct_id":"NCT07121829","title":"Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors","status":"TERMINATED","status_verified_date":"2025-08","start_date":"2022-05-02","start_date_type":"ACTUAL","primary_completion_date":"2024-12-18","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["DAWN"]}